Home › Funds › JERICHO FINANCIAL, LLP › ABT
JERICHO FINANCIAL, LLP position in ABT
ABBOTT LABORATORIES · Health Care
JERICHO FINANCIAL, LLP reported holding 43,398 shares of ABT (ABBOTT LABORATORIES) in its Q3 2026 13F filing — a position valued at US$4.3M, representing 2.12% of its reported portfolio and ranking #23 among its reported holdings. JERICHO FINANCIAL, LLP has disclosed ABT holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-10-15 · Source: SEC EDGAR Form 13F-HR
How JERICHO FINANCIAL, LLP's ABT position evolved
JERICHO FINANCIAL, LLP first disclosed a stake in ABT in Q4 2025 at 27,818 shares (US$3.5M). The position peaked in Q3 2026 at 43,398 shares, worth US$4.3M. Across 4 filings, JERICHO FINANCIAL, LLP increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 43,398 shares valued at US$4.3M — a reduction of -3,184 shares quarter over quarter.. Notable position changes include a 38% increase in Q2 2026 (shares rose 10% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 27.82K | $3.49M | New |
| Q1 2026 | 33.69K | $3.46M | Add |
| Q2 2026 | 46.58K | $4.23M | Add |
| Q3 2026 | 43.40K | $4.29M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ABT and 13F data
ABT (ABBOTT LABORATORIES) is a Health Care company. 20 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ABT
- Vanguard Group 175.56M sh · $22.00B · Q4 2025
- Charles Schwab Investment Management 59.67M sh · $5.41B · Q2 2026
- CHARLES SCHWAB INVESTMENT MANAGEMENT INC 59.67M sh · $5.41B · Q2 2026
- Sixth Street Partners Management Company, L.P. 59.67M sh · $5.41B · Q2 2026
- Capital Research Global Investors 36.91M sh · $3.35B · Q2 2026
- Capital Research Global Investors 36.91M sh · $3.35B · Q2 2026
- Capital International Investors 34.65M sh · $3.15B · Q2 2026
- Deutsche Bank AG 16.71M sh · $1.52B · Q2 2026
More on JERICHO FINANCIAL, LLP
FAQ
How long has JERICHO FINANCIAL, LLP held ABT?
JERICHO FINANCIAL, LLP has disclosed ABT holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is JERICHO FINANCIAL, LLP's current position in ABT?
As of Q3 2026, JERICHO FINANCIAL, LLP holds 43.40K shares of ABT (ABBOTT LABORATORIES), valued at $4.29M, representing 2.12% of its reported portfolio and ranking #23.
Has JERICHO FINANCIAL, LLP been buying or selling ABT?
In the latest 13F filing (Q3 2026), JERICHO FINANCIAL, LLP reduced its position in ABT. The position peaked in Q3 2026 at 43.40K shares.
Which other funds hold ABT?
Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 20 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.